Depósito Digital de Documentos de la UAB Encontrados 2 registros  La búsqueda tardó 0.02 segundos. 
1.
26 p, 1.8 MB Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis / Ordulu, Zehra (Department of Pathology, Massachusetts General Hospital, Boston, MA, United States) ; Chai, Hongyan (Department of Genetics, Yale University School of Medicine; New Haven, CT) ; Peng, Gang (Department of Biostatistics, Yale School of Public Health, New Haven, CT) ; McDonald, Anna G (Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC) ; De Nictolis, Michele (Department of Pathology, San Salvatore Hospital, Pesaro, Italy) ; Garcia-Fernandez, Eugenia (Department of Pathology, Hospital Universitario La Paz, IdiPAZ, and Faculty of Medicine, Universidad Autónoma de Madrid, Spain) ; Hardisson, David (Department of Pathology, Hospital Universitario La Paz, IdiPAZ, and Faculty of Medicine, Universidad Autónoma de Madrid, Spain) ; Prat, Jaime (Department of Pathology, Hospital de la Sta Creu i Sant Pau, Barcelona, Spain) ; Li, Peining (Department of Genetics, Yale University School of Medicine; New Haven, CT) ; Hui, Pei (Department of Pathology, Yale University School of Medicine; New Haven, CT) ; Oliva, Esther (Department of Pathology, Massachusetts General Hospital, Boston, MA, United States) ; Buza, Natalia (Department of Pathology, Yale University School of Medicine; New Haven, CT)
Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. [...]
2020 - 10.1038/s41379-020-0546-8
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 33 (april 2020) , p. 1844-1860  
2.
12 p, 3.2 MB Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type / Karnezis, Anthony N (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Wang, Yemin (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Ramos, Pilar (Translational Genomics Research Institute (TGen). Division of Integrated Cancer Genomics) ; Hendricks, William PD (Translational Genomics Research Institute (TGen). Division of Integrated Cancer Genomics) ; Oliva, Esther (Massachusetts General Hospital. Department of Pathology) ; D'Angelo, Emanuela (Institut d'Investigació Biomèdica Sant Pau) ; Prat, Jaime (Institut d'Investigació Biomèdica Sant Pau) ; Nucci, Marisa R (Brigham and Women's Hospital. Department of Pathology) ; Nielsen, Torsten O (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Chow, Christine (University of British Columbia. Genetic Pathology Evaluation Centre) ; Leung, Samuel (University of British Columbia. Genetic Pathology Evaluation Centre) ; Kommoss, Friedrich (Synlab MVZ Pathologie) ; Kommoss, Stefan (University Hospital of Tuebingen. Department of Obstetrics and Gynecology) ; Silva, Annacarolina (Harvard Medical School. The James Homer Wright Pathology Laboratories) ; Ronnett, Brigitte M (The Johns Hopkins Hospital. Department of Pathology) ; Rabban, Joseph T (University of California San Francisco. Department of Anatomic Pathology) ; Bowtell, David D (Peter MacCallum Cancer Centre) ; Weissman, Bernard E (University of North Carolina. Department of Pathology and Laboratory Medicine) ; Trent, Jeffrey M (Translational Genomics Research Institute (TGen). Division of Integrated Cancer Genomics) ; Gilks, C Blake (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Huntsman, David G (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Universitat Autònoma de Barcelona
Small cell carcinoma of the ovary, hypercalcaemic type () is a lethal and sometimes familial ovarian tumour of young women and children. We and others recently discovered that over 90% of harbour inactivating mutations in the chromatin remodelling gene with concomitant loss of its encoded protein (), one of two mutually exclusive of the / chromatin remodelling complex. [...]
2015 - 10.1002/path.4633
The Journal of Pathology, Vol. 238, Issue 3 (december 2015) , p. 389-400  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.